SG Americas Securities’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.11M | Buy |
235,532
+192,036
| +442% | +$1.72M | 0.01% | 675 |
|
2025
Q1 | $326K | Buy |
43,496
+2,146
| +5% | +$16.1K | ﹤0.01% | 1904 |
|
2024
Q4 | $311K | Sell |
41,350
-117,571
| -74% | -$884K | ﹤0.01% | 1548 |
|
2024
Q3 | $1.21M | Buy |
+158,921
| New | +$1.21M | ﹤0.01% | 810 |
|
2024
Q2 | – | Sell |
-13,548
| Closed | -$69K | – | 2440 |
|
2024
Q1 | $69K | Sell |
13,548
-52,675
| -80% | -$268K | ﹤0.01% | 2356 |
|
2023
Q4 | $397K | Buy |
+66,223
| New | +$397K | ﹤0.01% | 1468 |
|
2023
Q1 | – | Sell |
-12,791
| Closed | -$147K | – | 2944 |
|
2022
Q4 | $147K | Sell |
12,791
-8,641
| -40% | -$99.3K | ﹤0.01% | 2213 |
|
2022
Q3 | $270K | Sell |
21,432
-61,850
| -74% | -$779K | ﹤0.01% | 1851 |
|
2022
Q2 | $881K | Sell |
83,282
-153,563
| -65% | -$1.62M | 0.01% | 1264 |
|
2022
Q1 | $3.85M | Sell |
236,845
-29,370
| -11% | -$478K | 0.03% | 461 |
|
2021
Q4 | $3.69M | Sell |
266,215
-68,163
| -20% | -$944K | 0.02% | 578 |
|
2021
Q3 | $4.81M | Buy |
334,378
+324,142
| +3,167% | +$4.66M | 0.02% | 494 |
|
2021
Q2 | $162K | Sell |
10,236
-58,297
| -85% | -$923K | ﹤0.01% | 2196 |
|
2021
Q1 | $697K | Buy |
68,533
+10,448
| +18% | +$106K | ﹤0.01% | 1615 |
|
2020
Q4 | $433K | Sell |
58,085
-152,986
| -72% | -$1.14M | ﹤0.01% | 1834 |
|
2020
Q3 | $725K | Sell |
211,071
-723,877
| -77% | -$2.49M | ﹤0.01% | 1158 |
|
2020
Q2 | $4.46M | Buy |
934,948
+872,602
| +1,400% | +$4.16M | 0.04% | 302 |
|
2020
Q1 | $125K | Buy |
62,346
+42,146
| +209% | +$84.5K | ﹤0.01% | 2393 |
|
2019
Q4 | $70K | Buy |
+20,200
| New | +$70K | ﹤0.01% | 2585 |
|
2019
Q2 | – | Sell |
-20,744
| Closed | -$169K | – | 2552 |
|
2019
Q1 | $169K | Buy |
+20,744
| New | +$169K | ﹤0.01% | 2349 |
|
2017
Q4 | – | Sell |
-26,990
| Closed | -$141K | – | 2555 |
|
2017
Q3 | $141K | Buy |
26,990
+13,402
| +99% | +$70K | ﹤0.01% | 2529 |
|
2017
Q2 | $76K | Buy |
13,588
+1,436
| +12% | +$8.03K | ﹤0.01% | 2581 |
|
2017
Q1 | $102K | Sell |
12,152
-16,831
| -58% | -$141K | ﹤0.01% | 2639 |
|
2016
Q4 | $183K | Buy |
+28,983
| New | +$183K | ﹤0.01% | 2146 |
|
2016
Q2 | – | Sell |
-20,154
| Closed | -$57K | – | 2133 |
|
2016
Q1 | $57K | Buy |
+20,154
| New | +$57K | ﹤0.01% | 2397 |
|
2015
Q3 | – | Sell |
-8,031
| Closed | -$120K | – | 2058 |
|
2015
Q2 | $120K | Buy |
+8,031
| New | +$120K | ﹤0.01% | 1927 |
|
2015
Q1 | – | Sell |
-18,483
| Closed | -$225K | – | 2124 |
|
2014
Q4 | $225K | Buy |
+18,483
| New | +$225K | ﹤0.01% | 2068 |
|
2014
Q3 | – | Sell |
-10,369
| Closed | -$132K | – | 2178 |
|
2014
Q2 | $132K | Buy |
10,369
+162
| +2% | +$2.06K | ﹤0.01% | 1937 |
|
2014
Q1 | $108K | Buy |
+10,207
| New | +$108K | ﹤0.01% | 1922 |
|
2013
Q3 | – | Sell |
-21,870
| Closed | -$34K | – | 2484 |
|
2013
Q2 | $34K | Buy |
+21,870
| New | +$34K | ﹤0.01% | 1808 |
|